Loading stock data…
Loading stock data…
US$5.04
Get one email when CNSP crosses your level. Checked every 15 minutes during market hours.
▲ +0.30 (6.33%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
54.2
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.07
Bullish momentumMACD above its signal line (0.07).
50-day average
5.06
Price belowShort-term trend reference.
200-day average
5.31
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
CNS Pharmaceuticals Inc. is a preclinical stage biotechnology company dedicated to developing innovative anticancer drug candidates for treating primary and metastatic brain and central nervous system tumors. The company's primary focus is on glioblastoma multiforme, an aggressive and currently incurable form of brain cancer, along with other gliomas. CNS Pharmaceuticals maintains a specialized product pipeline including berubicin and CNS-12, targeting serious diseases in neurology and oncology.…
cnspharma.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-07-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-06-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-14 | -5.37 | -7.3 | ✗ Miss |
| 2026-03-31 | -5.09 | -10.15 | ✗ Miss |
| 2026-03-13 | 0.05 | 0.07 | ✓ Beat |
| 2026-02-10 | 0.96 | 1 | ✓ Beat |
| 2025-11-14 | -6.63 | -5.76 | ✓ Beat |
| 2025-10-14 | 0.45 | 0.51 | ✓ Beat |
| 2025-08-14 | -9.6 | -6.42 | ✓ Beat |
Companies in the same industry, via Finnhub